Home Correlation between plasma and urinary caffeine levels in preterm infants
Article
Licensed
Unlicensed Requires Authentication

Correlation between plasma and urinary caffeine levels in preterm infants

  • Luigi Cattarossi , Marco Violino , Franco Macagno , Paolo LoGreco and Marilena Savoia
Published/Copyright: August 1, 2006
Journal of Perinatal Medicine
From the journal Volume 34 Issue 4

Abstract

Background: We hypothesize that urine levels might be reliable to assess the therapeutic range of caffeine.

Objectives: We correlated plasma and urinary levels of caffeine in preterm infants treated with this drug for apnea of prematurity.

Methods: Infants (n=56) were given a loading dose of caffeine citrate (10 mg/kg, per os) and 24 h later a maintenance dose (2 mg/kg, per os, once a day). Plasma and urinary levels of caffeine were determined 24 h after the loading dose (before administration of the maintenance dose) and then weekly.

Results: Plasma and urinary levels correlate at all examined ages: 29 weeks (r=0.92, P<0.001), 30 weeks (r=0.97, P<0.001), 31 weeks (r=0.82, P<0.001), 32 weeks (r=0.92, P<0.001), 33 weeks (r=0.87, P<0.001), 34 weeks (r=0.81, P<0.001).

Conclusion: Urinary levels of caffeine might be a useful means to assess therapeutic ranges.

:

Corresponding author: Luigi Cattarossi MD Department of Pediatrics Via Morgagni 33028 Tolmezzo (UD) Italy Tel.: +390433488314 Fax: +390433488316

References

1 Millar D, B Schmidt: Controversies surrounding xanthine therapy. Semin Neonatol9 (2004) 239Search in Google Scholar

2 Gannon BA: Theophylline or caffeine: which is best for apnea of prematurity? Neonatal Netw19 (2000) 3310.1891/0730-0832.19.8.33Search in Google Scholar

3 Henderson-Smart DJ, P Steer: Prophylactic caffeine to prevent postoperative apnea following general anesthesia in preterm infants. Cochrane Database Syst Rev4 (2001) CD00004810.1002/14651858.CD000048Search in Google Scholar

4 Henderson-Smart DJ, P Steer: Methylxantine treatment for apnea in preterm infants. Cochrane Database Syst Rev3 (2001) CD00014010.1002/14651858.CD000074Search in Google Scholar

5 Aldridge A, JV Aranda, AH Neims: Caffeine metabolism in the newborn. Clin Pharmacol Ther25 (1979) 447Search in Google Scholar

6 Aranda JV, D Grondin, BI Sasyniuk: Pharmacologic consideration in the therapy of neonatal apnoea. Pediatr Clin North Am28 (1981) 113Search in Google Scholar

7 de Wildt SN, KT Kerkvliet, MG Wezenberg, S Otting, WC Hop, AG Vulto, et al.: Use of saliva in therapeutic drug monitoring of caffeine in preterm infants. Ther Drug Monit23 (2001) 250Search in Google Scholar

8 Sekkat N, A Naik, YN Kalia, P Glikfeld, RH Guy: Reverse iontophoretic monitoring in premature neonates: feasibility and potential. J Control Release81 (2002) 83Search in Google Scholar

9 Ginsberg G, D Hattis, A Russ, B Sonawane: Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risk from environmental agents. J Toxicol Environ Healt A67 (2004) 297Search in Google Scholar

10 al-Alaiyan S, S al-Rawithi, D Raines, A Yusuf, E Legayada, MM Shoukri: el-Yazigi Caffeine metabolism in premature infants. J Clin Pharmacol41 (2001) 620Search in Google Scholar

11 Curzi-Dascalova L, Y Aujart, C Gaultier, M Rajguru: Sleep organization is unaffected by caffeine in premature infants. J Pediatr140 (2002) 766Search in Google Scholar

12 Hoecker C, M Nelle, J Poeschl, B Beegden, O Linderkamp: Caffeine impairs cerebral and intestinal blood flow velocity in preterm infants. Pediatrics109 (2002) 784Search in Google Scholar

13 Baker MD: Theophylline toxicity in children. J Pediatr109 (1986) 54310.1016/S0022-3476(86)80140-8Search in Google Scholar

Published Online: 2006-08-01
Published in Print: 2006-08-01

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Advances in Perinatal Medicine - 5th Annual meeting of the Italian Society of Perinatal Medicine held in Parma, Italy on June 15th – 17th 2006
  2. Hemorrhagic shock in obstetrics
  3. Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR
  4. Gestational diabetes mellitus in patients receiving long-term corticosteroid therapy during pregnancy
  5. Accuracy and influence of ascorbic acid on glucose-test with urine dip sticks in prenatal care
  6. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study
  7. Timing of cord clamping revisited
  8. Intrapartum cardiotocography – the dilemma of interpretational variation
  9. Maturation of the autonomic nervous system: differences in heart rate variability in premature vs. term infants
  10. Four chamber view plus three-vessel and trachea view for a complete evaluation of the fetal heart during the second trimester
  11. Pleural fluid/serum immunoglobulin ratio is a diagnostic marker for congenital chylothorax in utero
  12. Fetal brain sparing is strongly related to the degree of increased placental vascular impedance
  13. Outcome of fetuses in women with pregestational diabetes mellitus
  14. Outcome of fetuses in women with pregestational diabetes mellitus
  15. Inhaled nitric oxide therapy might reduce the need for hyperventilation therapy in infants with persistent pulmonary hypertension of the newborn
  16. To drain or not to drain: a single institution experience with neonatal intestinal perforation
  17. Infective puerperal endocarditis caused by Escherichia coli
  18. Correlation between plasma and urinary caffeine levels in preterm infants
  19. Fetal ascites secondary to urinary hydrocolpos
  20. Congress Calendar
  21. Suppression of IL-2 and IFN-γ production in women with spontaneous preterm labor
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2006.067/html
Scroll to top button